Related Experiment Video
Updated: Aug 18, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Childhood acute myelomonocytic leukemia (AML-M4) presenting as catastrophic antiphospholipid antibody syndrome
Angela Orsino1, Rayfel Schneider, Gabrielle DeVeber
1Division of Rheumatology, Hospital for Sick Children, Toronto, Ontario, Canada.
Abstract:
: The authors describe a 15-year-old girl presenting with a cerebral ischemic stroke as the first manifestation of catastrophic antiphospholipid antibody syndrome secondary to acute myeloid leukemia (AML). Despite treatment with anticoagulants, therapeutic plasma exchange, and chemotherapy, the patient developed multiorgan thromboses and failure, eventually culminating in death. This unusual presentation of AML has not been previously described in children. Clinical features of antiphospholipid antibody syndrome and current knowledge regarding its association with malignancies are reviewed.
Related Concept Videos
Rocky Mountain Spotted Fever
Atypical Pneumonia
Bacterial Meningitis I: Introduction
Encephalitis l: Introduction

